Introduction
Both viral and non-viral gene delivery have been explored extensively for basic research as well as therapeutic applications. Viral gene delivery is typically more efficient than its non-viral counterpart but poses increased risks of immunogenicity, insertional mutagenesis and viral integration into the host genome. 1 While the integration event results in permanent transgene expression-which may not be desirable for all applications-it also provides a route for the prolonged expression of undesired viral components in host cells. As non-viral gene delivery relies on synthetic polymers or lipids and DNA that is explicitly free from viral components, it is generally considered a safer alternative than viral gene therapy. Therefore, there is a push to develop non-viral gene delivery materials to match the efficiency of viral vectors. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] In the pursuit of regenerative medicine, non-viral gene delivery is an important tool to manipulate and control cell fate. One of the latest applications of gene delivery is the reprogramming of terminally differentiated cells into induced pluripotent stem cells (iPSCs) or, more recently, induced neurons, blood progenitors and cardiomyocytes. [12] [13] [14] In the pioneering work of Yu et al., a recombinant lentivirus carrying the genes for OCT4, SOX2, NANOG and LIN28 was used to reprogram IMR-90 fetal lung fibroblasts into iPSCs. 15 While the resulting iPSCs were characteristically and functionally pluripotent, they nonetheless retained remnants of viral DNA as a result of lentiviral integration. This could have serious implications if tissue derived from such iPSCs was used therapeutically. Non-viral approaches to achieve safe, virus-free reprogramming of IMR-90 cells using synthetic polymers and lipids, however, have been fruitless as existing gene delivery materials have proven to be inefficient at mediating effective gene delivery in these cells. The genetic manipulation of human embryonic stem cells is an important tool in regenerative medicine. The control and over-expression of specific genes afforded by gene delivery are valuable not only in efforts to control stem cell fate, but also to study cell behavior in differentiation and gene targeting studies. 16 Unfortunately, recent efforts to develop new polymeric materials for the non-viral transfection of human embryonic stem cell colonies has resulted in only slightly increased efficiency compared to existing commercial products. 17 Polypeptides were among the first set of materials examined as non-viral gene delivery agents. [18] [19] [20] Given the simplicity in synthesis and formulation with anionic DNA, cationic poly-(L-lysine) (PLL) was one of the most intensively studied gene delivery polypeptides. However, as a DNA delivery vector, unmodified PLL suffered from low transfection efficiency. Even following modification with functional moieties like saccharide, 21, 22 imidazole 23 and guanidinium groups, 24 PLL has proven to be a largely ineffective gene delivery vector. Nonetheless, there have also been numerous attempts to create novel gene delivery vehicles with modified polypeptides, like poly-(glycoamidoamine)s 25 and HPMA-oligolysines. 26 Many biologically active peptides share facially amphipathic helical domains as a common structural motif. 27, 28 Peptides which possess this structure are often able to interact with and destabilize the lipid bilayers of cell membranes. In terms of gene delivery, cell membrane destabilization can facilitate cell internalization and escape from endocytic vesicles. 29, 30 PLL and modified PLL, however, adopt random coil structures because strong intramolecular side-chain charge repulsion prohibits α-helix formation. As such, PLL functions as a conventional polyelectrolyte in gene delivery studies and exhibits limited membrane activity. Recently, we reported a new cationic polypeptide possessing a pH-, ionic-and temperature-stable cationic helical structure. 31 Traditionally, charged polypeptides adopt random coil orientations because strong intramolecular side-chain charge repulsion prohibits α-helix formation. In our reported polypeptide, termed PVBLG n -8 where n is the degree of polymerization, the helical structure is stabilized by increasing the distance between the charged side chain groups and the polypeptide backbone. This has the net effect of both minimizing the effect of charge repulsion while simultaneously stabilizing the helix through hydrophobic interaction between the pendent side chain groups. Our prior characterization of PVBLG n -8 peptides as non-viral gene delivery materials revealed that the helical structure facilitates strong, disruptive interactions with cell membranes which aid the endosomal escape of the endocytosed complexes of polypeptide and DNA. 32 Although gene delivery with PVBLG n -8 proved to be effective in COS-7 and HEK 293 cells with comparable performance to the commercial transfection agent Lipofectamine 2000, 32 it was largely ineffective in IMR-90 fibroblasts due to its substantial toxicity in these cells. Here, we report the design and synthesis of a diblock copolymer incorporating polyethylene glycol (PEG) to the PVBLG n -8 polypeptide. We demonstrate that the addition of PEG to PVBLG n -8 markedly decreases the toxicity of PVBLG n -8 yet preserves the biological activity and gene delivery efficiency of the polypeptide. Moreover, with its reduced toxicity, PEG-b-PVBLG-8 is able to effectively transfect IMR-90 fibroblasts and human embryonic stem cells (Scheme 1), which suggests that it may be possible to ultimately achieve higher reprogramming efficiency of fibroblasts with a safer non-viral vector.
Materials and methods

General
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA) and used as received unless otherwise specified. Anhydrous dimethylformamide (DMF) was dried by a column packed with 4 Å molecular sieves and stored in a glovebox. Tetrahydrofuran (THF) and hexane were dried by a column packed with alumina and stored in a glove box. 
General procedure for the polymerization of VB-Glu-NCA
We followed a previously established procedure to synthesize and polymerize NCAs to prepare polypeptides. [35] [36] [37] [38] In a glovebox, VB-Glu-NCA (56 mg, 0.2 mmol) was dissolved in DMF (1 mL) followed by the addition of PEG-amine and 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD) at various monomer : amine : TBD ratios ( Table 1 ). The polymerization solutions were stirred at room temperature for 24-60 h untill VB-Glu-NCA was consumed. Aliquots of the polymerization solutions were diluted to 10 mg polymer mL −1 using DMF containing 0.1 M LiBr and analyzed by GPC. The real-time concentration of NCA was quantified by measuring the intensity of the anhydride band at 1784 cm −1 by FTIR. The conversion of VB-Glu-NCA was determined by comparing the VB-Glu-NCA concentration in the polymerization solution versus the initial VB-Glu-NCA concentration. When the polymerization was complete, the majority of the DMF was removed under vacuum and the polymer was precipitated with ether (15 mL 
General procedure for the synthesis of poly(ethylene
PEG-b-PVBLG (40 mg) was dissolved in chloroform (30 mL) at −78°C. Oxygen was then bubbled into the solution for 1 min followed by the bubbling of ozone until the solution became blue. The ozone was then replaced by oxygen, which was bubbled into the solution for 2 min until the solution became colorless. The solution was degassed and back filled with nitrogen. Dimethyl sulfide (1 mL) was then added and the solution was stirred at room temperature overnight. Afterwards, the solvent was removed under vacuum and the resulting PEG 113 -b-PABLG 76 was purified by sonicating the polymer in methanol (3 × 15 mL) and collected by centrifugation. PEG-b-PABLG (20 mg), N-(2-aminoethyl)piperidine (5 molar equiv. relative to the Glu repeating unit of PEG-b-PABLG) and borane-pyridine complex (5 molar equiv.) were mixed in DMF (3 mL) and stirred at 50°C for 48 h ( Table 2 ). The mixture was poured into 3 M HCl (3 mL) and dialyzed against water for 48 h. The resulting PEG-b-PVBLG-8 was lyophilized. The yields of PEG-b-PVBLG-8 copolymers were between 60 and 70%, with grafting efficiencies greater than 95%, which was determined as previously reported. Circular dichroism studies were performed on JASCO J-700 and J-720 CD spectrometers. Samples were prepared at polymer concentrations of 0.01-0.1 mg mL −1 unless otherwise specified. In a representative experiment, the sample solution was placed in a quartz cell with a path length of 0.5 cm and the mean residue molar ellipticity of the polymer was calculated based on the measured apparent ellipticity according to the equation: Ellipticity ([θ] in degree cm 2 dmol −1 ) = (millidegrees × mean residue weight)/( path length in millimeters × concentration of polypeptide in mg mL −1 ). 39 For helix-temperature dependency studies, the temperature of the sample chamber containing the quartz cell was varied from 4 to 70°C using a water bath. A minimum of 10 min was allowed for sample temperature equilibration prior to collecting CD measurements. The α-helix contents of the polypeptides were calculated using the following equation: % α-helix = (−[θ] 222 + 3000)/39 000. 40 
Agarose gel retardation
A solution of DNA (0.5 μg) was prepared in OptiMEM (50 μL).
Separately, a solution of polypeptide in OptiMEM (50 μL) was prepared to achieve the desired polypeptide : DNA weight ratio. Following mixing of the two solutions, complexes were incubated at room temperature for 20 min, after which an aliquot (20 μL) was withdrawn and a loading dye (4 μL) was added.
The mixture was then run on a 2% agarose gel (100 V, 60 min). DNA was stained with ethidium bromide and visualized on a Gel Doc imaging system (Biorad, Herclues, CA, USA). diluted with OptiMEM (50 μL). The individual solutions were then mixed gently and allowed to incubate for 5 min at rt, after which they were combined and allowed to incubate at rt for another 20 min. The cell medium was then aspirated and replaced with pre-warmed (37°C) OptiMEM (500 μL). The complex solution was added dropwise to the cells. The cells were then incubated at 37°C with 5% CO 2 for 4 h, after which the cell medium was replaced with normal culture medium (500 μL). After incubation for a total of 48 h at 37°C with 5% CO 2 , the cells were imaged with a fluorescent microscopy. The EGFP transfection efficiency was quantified by flow cytometry.
Sample preparation and flow cytometry analysis
Prior to analysis by flow cytometry, transfected cells on the 24-well plate were washed with 1× PBS (500 μL for each well) to remove any residual serum, dead cells and debris. Next, trypsin (100 μL) was added and incubated for 5-10 min to detach the cells from the plate. PBS (100 μL) was then added and pipetted up and down to break up cell clumps. A solution of 4% paraformaldehyde (100 μL) was added to fix the cells. Samples were kept in covered flow cytometry tubes until analysis (BD FACSCanto, Franklin Lakes, NJ, USA).
MTT assay of polymers
For MTT assays, 10 000 cells were seeded in each well of a 96-well plate one day before transfection. The cells were then transfected as described above, save for an 80% reduction in volume and reagent quantity to accommodate the reduced well volume. The cells were incubated for 4 h at 37°C in the transfection mix before being returned to a fresh growth medium. After 48 h, the cells were washed with PBS and an MTT solution was added. Following a 4 h incubation at 37°C, an MTT solubilization solution (10% Triton X-100 in acidic (0.1 M HCl) isopropanol) was added to the cells and the absorbance of 570 nm light was quantified on a PerkinElmer plate reader (Waltham, MA, USA).
hESC transfection
hESCs were seeded in Matrigel-coated 24-well plates. Plasmid DNA (1 μL, 1 mg mL −1 ) was diluted in OptiMEM (50 μL). The polymer solution (10-40 μL, 1 mg mL −1 ) was diluted with OptiMEM (50 μL). The two solutions were then vortexed gently and allowed to incubate for 5 min at rt, after which they were combined and allowed to incubate for another 20 min at rt. ).
d The α-helix contents of the polypeptides were calculated using the following equation: % α-helix = (−[θ] 222 + 3000)/39 000. 40 Next, the mixtures were added to the cells dropwise and allowed to incubate at 37°C for 4 h. The medium was then aspirated and fresh medium was added. After 48 h, the cells were stained with DAPI (250 μL, 3 nM) and SSEA-4-PE (250 μL, 0.02 mg mL −1 ), a pluripotency cell marker, for 30 min at 37°C.
Results
Synthesis and characterization of PEG-b-PVBLG-8 (PEV)
γ-(4-Vinylbenzyl)-L-glutamate N-carboxyanhydride (VB-Glu-NCA) was prepared by following previously reported methods. 31, 32, 34 The ring-opening polymerization of VB-Glu-NCA with PEGamine as the macroinitiator yielded PEG-block-poly(γ-(4-vinylbenzyl)-L-glutamate) (PEG-b-PVBLG) with controlled molecular weights (MWs) and narrow molecular-weight distributions (Scheme 2). At the VB-Glu-NCA-PEG-amine ratio of 100, the obtained M n of 20.7 × 10 3 g mol −1 agreed well with the theoretical M n of 24.6 × 10 3 g mol −1 and had a narrow molecular weight distribution of 1.21 (entry 1, Table 1 ). Two PEG-b-PVBLG copolymers were prepared with degrees of polymerization (DP) of 76 (PEG-b-PVBLG 76 ) and 287 (PEG-b-PVBLG 287 ) of the PVBLG block ( Table 1) .
The ozonation of PEG-b-PVBLG yielded PEG-bpoly(γ-(4-aldehydebenzyl-L-glutamate) (PEG-b-PABLG), which served as the reactive intermediate that, through subsequent hydroamination and reduction with N-(2-aminoethyl)piperidine, yielded the desired PEG-b-PVBLG 76 -8 (PEV-L) and PEG-b-PVBLG 287 -8 (PEV-H). Grafting efficiencies greater than 95%
were achieved for both PEV-L and PEV-H (Table 2) . Both PEV-L and PEV-H are highly soluble in water at pH 1-10 (>50 mg mL −1 ), which is drastically different from the corresponding parental (PEG-b-PVBLG) and intermediate polymers (PEG-b-PABLG) that are insoluble in water. The excellent water solubility of PEV-L and PEV-H is clearly related to their charged side groups, which make it possible for the application of PEV at physiological pH. Both PEV-L and PEV-H showed the characteristic CD spectra of an α-helix with two minima at 208 and 222 nm (Fig. 1a) , consistent with our previously reported α-helical conformation of PVBLG-8.
32,41
Helical contents of greater than 90% were observed for both PEV-L and PEV-H at pH 3 when the side chain amine groups are protonated ( Table 2) . As expected, the charge repulsion of the side groups had minimal effect on helix stability because the charged amine groups were placed far away from the polypeptide backbone. Furthermore, the helicity-as measured by the value of −[θ] 222 -was shown to be stable against pH and salt changes in the surrounding environment. For example, the −[θ] 222 values of PEV-L and PEV-H remained unchanged when the solution pH was increased from 1 to 9 (Fig. 1b) . The helices of PEV-L and PEV-H were also fairly stable in concentrated denaturing conditions, such as in 1 M NaCl (Fig. 1d ) and 2 M urea (Fig. 1d ) aqueous solutions. These observations suggested that PEVs would maintain their helical conformation in various extracellular and intracellular environments with well-preserved properties throughout the gene transfection processes.
Complex formation with PEG-b-PVBLG-8 with DNA. The ability of PEG-b-PVBLG-8 to bind and complex with DNA was examined using a gel retardation assay. Polymer was mixed with plasmid DNA at DNA : polymer weight ratios between 1 : 1 and 1 : 60 and run on an agarose gel. The results for PEV-L can be seen in Fig. 2a . The addition of polymer in excess of 1 : 2 (DNA : polymer weight ratio) resulted in the formation of stable complexes which prohibited the migration of DNA 
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under an electrophoretic force. Interestingly, at a 1 : 2 DNA : polymer weight ratio, the DNA could still be seen in the loading well, indicating incomplete condensation. However, the DNA was no longer visible when sufficient polymer was added to achieve a 1 : 10 DNA : polymer weight ratio, indicating complete condensation. As can be seen in Fig. 1a , DNA binding does not affect the α-helicity of the peptide.
Dynamic light scattering
Dynamic light scattering revealed complexes formed between DNA and Lipofectamine 2000 at a 1 : 2 DNA : Lipofectamine 2000 weight ratio to be approximately 574 nm in diameter. Meanwhile, the hydrodynamic diameters of complexes of PEV-L and PEV-H at a 1 : 40 DNA : polymer weight ratio were substantially smaller-about 107 nm and 246 nm for PEV-L and PEV-H, respectively (Fig. 2b) . Testing of DNA : polymer weight ratios less than and greater than 1 : 40 did not dramatically change the measured diameter-provided that a minimum amount of polymer was added to achieve complexation. For example, the diameters of complexes made with DNA : PEV-L weight ratios of 1 : 10, 1 : 20, 1 : 40 and 1 : 80 were 117 nm, 115 nm, 107 nm, and 84 nm, respectively. This suggests that once a minimum amount of polypeptide is present-presumably enough to achieve a 1 : 10 DNA : polymer weight ratio based on Fig. 2a -the excess polymer is not incorporated into the complexes and exists freely in the solution. Furthermore, despite the rod-like structure of the helical polypeptide, complexes formed between DNA and PEG-PVBLG-8 possessed a globular structure under TEM (Fig. 2c) . Zeta potential measurements were performed to ensure that the complex formed between PEV-L (or PEV-H) and DNA were overall positively charged. PEV-DNA complexes formed possessed zeta potentials between 2 and 10 mV, while PVBLG-8/ DNA complexes possessed zeta potentials between 20 and 30 mV (data not shown). The addition of the PEG block to the polypeptide shielded the cationic charge of the PVBLG-8 block.
Toxicity
The toxicity of the PEV-H was compared with PVBLG-8 homopolymer (P0) and Lipofectamine 2000 via MTT assays in IMR-90 cells. PVBLG-8 (P0) was found to be notably toxic to IMR-90 cells. At 1 : 40 DNA : polymer weight ratio, a viability of 6% was observed. The new diblock polymers of both low (PEV-L) and high (PEV-H) molecular weight showed substantially reduced toxicity to IMR-90 cells (Fig. 3a) . Increasing the DNA : polymer ratio resulted in increased toxicity for both PEV-L and PEV-H polymers. PEV-H-DNA complexes showed slightly reduced toxicity compared to the PEV-L-DNA complex, but both PEV-L-and PEV-H polymers were less toxic than Lipofectamine 2000 under similar conditions.
Transfection
Transfection experiments were performed with the diblock copolymers to determine whether their reduced toxicity impacted their ability to effectively deliver genes to IMR-90 cells. As shown in Fig. 3b , the commercial reagent Lipofectamine 2000 resulted in approximately 19% of treated cells expressing the delivered GFP transgene. Unmodified PVBLG-8 (P0), on the other hand, had a transfection efficiency of only 1.4% with low cell viability. While PVBLG-8 performed comparable to Lipofectamine 2000 in COS-7 and HeLa cells in previous studies, its poor performance as shown in Fig. 3b is likely due to the excessive toxicity of the polypeptide in IMR-90 cells. Reducing the toxicity of PVBLG-8 through the addition of PEG blocks resulted in an increase in IMR-90 transfection efficiency of 9.4% and 21.4% for PEV-L and PEV-H, respectively. Because of the reduced toxicity of PEV-L and PEV-H, the DNA dosage could be increased from 1 μg to 2 μg, which resulted in slightly higher transfection efficiencies, 13% and 27%, for PEV-L and PEV-H formulations, respectively (data not shown). Although this increase in efficiency was modest, it should be highlighted To further demonstrate the application of PEG-b-PVBLG-8, we next evaluated the gene delivery efficiency to H1 hESC. PEV-H transfection in separated H1 cells resulted in higher transfection efficiency than in cells plated as colonies (Fig. 4a  and b) . Moreover, the polymer was shown to have no impact on hESC pluripotency 48 h post-transfection. This was evidenced by the similar expression of stage-specific embryonic antigen-4 (SSEA-4) both before and after transfection in colonies and single cells (Fig. 4c) . Further evidence of pluripotency was shown through a Western blot of the OCT4 pluripotency transcription factor before and after transfection with PEV-H (Fig. 4d) . Combined with its efficiency, the mild cell impact of the PEV-H made it a promising reagent to manipulate the gene expression of human stem cells.
Discussion
Transfection efficiency is often limited due to the toxicity of vectors. Generally, the more efficient the transfection material, the greater the impact it may have on cell health. This is largely due to the requirements of effective gene deliverynamely, a high polycationic charge to condense DNA and enable cell surface binding and membrane-lytic properties to facilitate intracellular escape from endocytic vesicles. While good for the delivery of nucleic acids, highly cationic materials can also bind and interfere with the function of necessary proteins within the cell. Moreover, the membrane lytic effect of materials can be unspecific and may act in a desirable as well as an undesirable manner. Effective gene delivery materials are able to balance their positive and negative tendencies so that they are efficient enough to allow macromolecules like DNA to enter the cells but safe enough that the cells are not irreparably damaged during the process. In this paper, we focus on the previously described PVBLG-8 materials and try to reduce their overall toxicity while maintaining their effective gene delivery performance.
Previous characterizations of the helical polypeptide PVBLG-8 revealed that it can operate as an effective delivery vector for both DNA and siRNA. 41 In both cases, its performance was demonstrated to be tied to its ability to form stable helices that cause pore formation within membranes. In the case of DNA delivery, the membrane lytic potential was essential to the escape of DNA-polypeptide complexes from endocytic vesicles. In the case of siRNA delivery, the helical PVBLG-8 caused pore formation within cell membranes to allow the non-endocytic diffusion of siRNA into the cell cytosol. Therefore, in our desire to reduce the toxicity of the PVBLG-8 materials, it was also essential to retain their helical structure. Unfortunately, just as helicity makes the materials effective delivery agents, it is also a contributing factor to overall toxicity. As such, we sought a strategy to append charge shielding materials to the helical PVBLG-8. By shielding the positive charge, we hoped to minimize the toxicity of the material by reducing its electrostatic attraction with negatively charged cell membranes. At the same time, since the helicity of the PVBLG-8 block was maintained (Fig. 1a) , we hoped that the material would retain its ability to effectively escape the endosome and mediate effective gene delivery (Scheme 1).
To test the feasibility of incorporation of charge shielding groups, PEG was covalently conjugated with PVBLG-8 to yield the diblock polymer PEG-b-PVBLG-8. The PEG used had a MW of 5000 Da (DP of 113) and was conjugated to helical PVBLG-8 with DPs of 76 and 287 to yield the diblock materials PEV-L and PEV-H, respectively (Scheme 2). Circular dichroism experiments revealed that the incorporation of PEG did not alter the presence and stability of the helices even after the DNA is bound and condensed by the peptide (Fig. 1a) . Moreover, the materials were also able to bind and condense plasmid DNA into spherical particles with diameters of the order of 100 nm (Fig. 2a-c) . Despite the inclusion of PEG, these particles were demonstrated to retain an overall positive surface charge similar to commercial materials like Lipofectamine 2000 by analyzing their surface zeta potential (data not shown).
Toxicity measurements with the diblock materials revealed that the inclusion of a PEG block substantially increased the biocompatibility of the materials in IMR-90 cells. For example, treatment with the unmodified PVBLG-8 left only approximately 5% of IMR-90 cells viable. However, with the addition 
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Paper of a PEG block, cell viability increased dramatically and was less toxic than Lipofectamine 2000 (Fig. 3a) . With its improved toxicity profile, PEG-b-PVBLG-8 was able to mediate effective transfection in IMR-90 cells. Previously, the toxicity of the materials was so extreme that only 1.4% of cells were successfully transfected. With the reduced toxicity, that number was increased to approximately 20%-an increase of approximately 14-fold. With its improved safety profile, PEG-b-PVBLG-8 was mild enough to transfect H1 human embryonic stem cells without affecting the expression of cell pluripotency markers (Fig. 4) .
Conclusions
We prepared diblock copolymers consisting of poly ( In contrast to many other polymer-and lipid-based transfection systems which utilize the proton sponge mechanism (e.g. polyethylenimine) or lipid mixing (e.g. DOTAP, DOPE, etc.) to facilitate endosomal escape, the peptides described here make use of a novel pore formation mechanism. As endocytic escape is generally considered one of the most challenging aspects of gene delivery, this alternative endosomolytic mechanism may prove useful when working with cell lines not readily amenable to transfection by current methods (i.e. IMR-90 and hES cells).
As both IMR-90 and hESCs are important cell lines that are commonly used in the field of regenerative medicine, effective non-viral gene delivery to these cells is an important step in bringing regenerative medicine closer to clinical applications.
